Avita Therapeutics Inc

Healthcare AU AVH

3.82AUD
0.14(3.80%)

Last update at 2024-11-13T05:10:00Z

Day Range

3.773.87
LowHigh

52 Week Range

2.345.62
LowHigh

Fundamentals

  • Previous Close 3.68
  • Market Cap474.31M
  • Volume374918
  • P/E Ratio-
  • Dividend Yield-%
  • EBITDA-53.54900M
  • Revenue TTM54.14M
  • Revenue Per Share TTM2.12
  • Gross Profit TTM 28.38M
  • Diluted EPS TTM-0.59

Financials

Income Statement

Balancesheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2023-06-30 2022-06-30 2021-06-30 2020-06-30 2019-06-30
Type yearly yearly yearly yearly yearly
Date 2023-06-30 2022-06-30 2021-06-30 2020-06-30 2019-06-30
Income before tax -26.62900M -34.54513M -26.54500M -42.02600M -24.75004M
Minority interest - - - - -
Net income -26.66500M -34.60293M -26.58300M -42.03000M -24.62408M
Selling general administrative 23.33M 28.83M 22.40M 34.62M 12.67M
Selling and marketing expenses 21.91M 22.39M 14.66M 14.81M 12.31M
Gross profit 28.38M 37.05M 23.28M 11.29M 4.21M
Reconciled depreciation 0.57M - 0.71M 0.47M 0.26M
Ebit -27.50500M -34.51210M -27.23800M -41.99300M -24.98832M
Ebitda -26.04500M -33.58585M -26.52300M -41.52800M -24.72359M
Depreciation and amortization 1.46M 0.93M 0.71M 0.47M 0.26M
Non operating income net other - - - - -
Operating income -27.50500M -34.51210M -26.54000M -42.67900M -24.72359M
Other operating expenses 61.93M 63.16M 55.77M 56.94M 30.44M
Interest expense 0.02M 0.04M 0.02M 0.03M 0.03M
Tax provision 0.04M 0.03M 0.04M 0.00400M -0.17986M
Interest income 0.02M 0.02M 0.02M 0.03M -
Net interest income -0.01600M - -0.02200M -0.03300M -0.03777M
Extraordinary items - - - - -
Non recurring - - - - -
Other items - - - - -
Income tax expense 0.04M 0.06M 0.04M 0.00400M -0.12597M
Total revenue 34.42M 45.45M 29.23M 14.26M 5.40M
Total operating expenses 55.88M 71.56M 49.82M 53.97M 29.25M
Cost of revenue 6.04M 8.40M 5.95M 2.97M 1.19M
Total other income expense net 0.88M -0.03303M 0.02M 0.69M 0.32M
Discontinued operations - - - 1.54M -8.56421M
Net income from continuing ops -26.66500M - -26.58300M -42.03000M -35.16023M
Net income applicable to common shares -26.66500M -28.85400M -26.58300M -42.03000M -25.10200M
Preferred stock and other adjustments - - - - -
Breakdown 2024-06-30 2023-06-30 2022-06-30 2021-06-30 2020-06-30
Type yearly yearly yearly yearly yearly
Date 2024-06-30 2023-06-30 2022-06-30 2021-06-30 2020-06-30
Total assets 111.64M 98.26M 159.67M 125.50M 82.46M
Intangible assets 0.49M 0.47M 0.61M 0.47M 0.36M
Earning assets - - - - -
Other current assets - 1.03M 0.20M 1.33M 0.99M
Total liab 62.58M 13.52M 12.59M 9.85M 10.06M
Total stockholder equity 49.06M 84.74M -324.69670M 115.66M 72.40M
Deferred long term liab - - 0.50M 0.61M -
Other current liab 0.34M 6.88M 8.86M 4.27M 3.38M
Common stock - 0.00300M 0.00413M 0.00300M 0.00300M
Capital stock 0.00300M 0.00300M - 0.00300M 0.00300M
Retained earnings -297.96900M -262.58800M -324.70082M -221.49600M -194.91300M
Other liab - 2.52M 1.33M 1.58M 0.43M
Good will - - - - -
Other assets - 1.36M 1.30M 0.76M 0.00100M
Cash 22.12M 18.16M 76.40M 110.75M 73.64M
Cash and equivalents - - 55.51M 110.75M -
Total current liabilities 13.20M 10.69M 12.59M 7.39M 7.71M
Current deferred revenue - 0.19M - - -
Net debt 17.69M -17.24600M -76.39979M -109.86800M -71.72200M
Short term debt - 0.61M 0.00000M 0.00000M 0.00000M
Short long term debt - - - - -